Healthcare and Research @batjamesbakerposts-blog - Tumblr Blog

The adoption of Accenture’s IT services by insurance intermediary Towergate is a recent example of enterprises’ action plan for integration of their services.

European communication and technology industry presently observes strategic business activities in its favor. The adoption of Accenture’s IT services by insurance intermediary Towergate is a recent example of enterprises’ action plan for integration of their services. “To ensure we pave the way for growth, we are transforming our entire IT infrastructure to positively change how we run our business and serve our diverse client base,” said Gordon Walters, CIO, Towergate.

#Cloud #cloud services #cloud service market #europe

Ovarian Disease Global Clinical Trials Review, H2, 2015

Ovarian Disease Global Clinical Trials Review, H2, 2015 provides an overview of Ovarian Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Ovarian Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

Enquiry about report: http://www.researchbeam.com/ovarian-disease-global-clinical-trials-review-h2-2015-market/enquire-about-report

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Table of Content

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Ovarian Disease to Women's Health Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Ovarian Disease to Women's Health Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Subjects Recruited Over a Period of Time 25

Clinical Trials by Sponsor Type 26

Prominent Sponsors 27

Top Companies Participating in Ovarian Disease Therapeutics Clinical Trials 28

Prominent Drugs 30

Clinical Trial Profile Snapshots 31

Appendix 125

Abbreviations 125

Definitions 125

Research Methodology 126

Secondary Research 126

About GlobalData 127

Contact Us 127

Disclaimer 127

Source 128

List of Tables

Ovarian Disease Therapeutics, Global, Clinical Trials by Region, 2015* 6

Ovarian Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Ovarian Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Ovarian Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Ovarian Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Ovarian Disease Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Ovarian Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Ovarian Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Ovarian Disease to Women's Health Clinical Trials, G7 Countries (%), 2015* 15

Ovarian Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Ovarian Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Ovarian Disease to Women's Health Clinical Trials, E7 Countries (%), 2015* 18

Ovarian Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Ovarian Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Ovarian Disease Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Ovarian Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Ovarian Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Ovarian Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Ovarian Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Ovarian Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26

Ovarian Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Ovarian Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Ovarian Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

List of Figures

Ovarian Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Ovarian Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Ovarian Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Ovarian Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Ovarian Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Ovarian Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Ovarian Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Proportion of Ovarian Disease to Women's Health Clinical Trials, G7 Countries (%), 2015* 15

Ovarian Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Ovarian Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Ovarian Disease to Women's Health Clinical Trials, E7 Countries (%), 2015* 18

Ovarian Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Ovarian Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Ovarian Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Ovarian Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Ovarian Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Ovarian Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Ovarian Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Ovarian Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26

Ovarian Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Ovarian Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28

Ovarian Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 126

Source: http://www.researchbeam.com/ovarian-disease-global-clinical-trials-review-h2-2015-market

About Us:

With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Web: http://www.researchbeam.com

Email Us: [email protected]

LinkedIn: http://www.linkedin.com/company/research-beam

China Anesthesia and Respiratory Devices Market Outlook to 2021

China Anesthesia and Respiratory Devices Market Outlook to 2021 Airway and Anesthesia Devices, Anesthesia Machines, Pain Management Devices, Regional Anesthesia Disposables, Respiratory Devices, Respiratory Disposables and Others, provides key market data on the China Anesthesia and Respiratory Devices market. The report provides value, in millions of US dollars, and volume (in units) within market categories Airway and Anesthesia Devices, Anesthesia Machines, Pain Management Devices, Regional Anesthesia Disposables, Respiratory Devices, Respiratory Disposables, Respiratory Measurement Devices and Sleep Apnea Diagnostic Systems.

Enquiry about report: http://www.researchbeam.com/china-anesthesia-and-respiratory-devices-outlook-to-2021-airway-and-anesthesia-devices-anesthesia-machines-pain-management-devices-regional-anesthesia-disposables-respiratory-devices-respiratory-dispo-market/enquire-about-report

Scope

Market size and company share data for Anesthesia and Respiratory Devices market categories Airway and Anesthesia Devices, Anesthesia Machines, Pain Management Devices, Regional Anesthesia Disposables, Respiratory Devices, Respiratory Disposables, Respiratory Measurement Devices and Sleep Apnea Diagnostic Systems.

Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.

2014 company shares and distribution shares data for each of the market categories.

Global corporate-level profiles of key companies operating within the China Anesthesia and Respiratory Devices market.

Key players covered include Medtronic plc, Philips Respironics, Inc., Draegerwerk AG & Co. KGaA, ResMed Inc., GE Healthcare, Smiths Medical, Teleflex Incorporated and others.

Table of Content

1 Table of Contents 2 1.1 List of Tables 8 1.2 List of Figures 11 2 Introduction 15 2.1 What Is This Report About? 15 2.2 Anesthesia and Respiratory Devices Market Segmentation 15 3 Anesthesia and Respiratory Devices Market, China 29 3.1 Anesthesia and Respiratory Devices Market, China, Revenue ($m), 2007-2021 29 3.2 Anesthesia and Respiratory Devices Market, China, Revenue Mix ($m), 2014 31 4 Airway and Anesthesia Devices Market, China 48 4.1 Airway and Anesthesia Devices Market, China, Revenue Mix ($m), 2014 48 4.2 Airway and Anesthesia Devices Market, China, Segment Contribution (%), 2014 49 5 Anesthesia Machines Market, China 101 5.1 Anesthesia Machines Market, China, Revenue Mix ($m), 2014 101 5.2 Anesthesia Machines Market, China, Segment Contribution (%), 2014 102 6 Pain Management Devices Market, China 114 6.1 Pain Management Devices Market, China, Revenue ($m), 2007-2014 114 6.2 Pain Management Devices Market, China, Revenue ($m), 2014-2021 115 7 Regional Anesthesia Disposables Market, China 121 7.1 Regional Anesthesia Disposables Market, China, Revenue Mix ($m), 2014 121 7.2 Regional Anesthesia Disposables Market, China, Segment Contribution (%), 2014 122 8 Respiratory Devices Market, China 158 8.1 Respiratory Devices Market, China, Revenue Mix ($m), 2014 158 8.2 Respiratory Devices Market, China, Segment Contribution (%), 2014 159 9 Respiratory Disposables Market, China 203 9.1 Respiratory Disposables Market, China, Revenue Mix ($m), 2014 203 9.2 Respiratory Disposables Market, China, Segment Contribution (%), 2014 204 10 Respiratory Measurement Devices Market, China 224 10.1 Respiratory Measurement Devices Market, China, Revenue Mix ($m), 2014 224 10.2 Respiratory Measurement Devices Market, China, Segment Contribution (%), 2014 225 11 Sleep Apnea Diagnostic Systems Market, China 253 11.1 Sleep Apnea Diagnostic Systems Market, China, Revenue Mix ($m), 2014 253 11.2 Sleep Apnea Diagnostic Systems Market, China, Segment Contribution (%), 2014 254 12 Overview of Key Companies in China, Anesthesia and Respiratory Devices Market 266 12.1 Smiths Medical 266 12.2 Philips Respironics, Inc. 266 13 Anesthesia and Respiratory Devices Market Pipeline Products 272 14 Financial Deals Landscape 274 14.2 Debt Offerings 277 Cheng Minghe 284 15 Appendix 285 15.1 Research Methodology 286 15.2 GlobalData Consulting 287

Source: http://www.researchbeam.com/china-anesthesia-and-respiratory-devices-outlook-to-2021-airway-and-anesthesia-devices-anesthesia-machines-pain-management-devices-regional-anesthesia-disposables-respiratory-devices-respiratory-dispo-market

About Us:

With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Web: http://www.researchbeam.com

Email Us: [email protected]

LinkedIn: http://www.linkedin.com/company/research-beam

Endoscopy - APAC Analysis and Market Forecasts

The Asia-Pacific (APAC) Endoscopy market is a dynamic market that is expected to grow through 2021. The market is facing intense competition due to the availability of similar product offerings across market players. In the face of increasing hospital consolidation into one network and the trend of oligopoly purchasing, i.e. purchasing more products from fewer manufacturers, the adoption pattern within the endoscopy space has become not entirely product performance based, but also strong brand awareness and identity has become a necessity.

Enquiry about report: http://www.researchbeam.com/endoscopy-apac-analysis-and-forecasts-market/enquire-about-report

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Executive Summary

2.1 Sales for the Endoscopy Market

2.2 Market Dynamics

3 Introduction

3.1 Catalyst

3.2 Related Reports

4 Industry Overview

4.1 Indications

4.2 Clinical Outcomes

5 Pratice Patterns and Adoption Trends

5.1 Survey Data Analysis

5.2 Adoption Trends

6 Unmet Needs

6.1 Endoscope Design Challenges

6.2 Addressing the Complications

7 Market Drivers, Opportunities and Barriers

7.1 Drivers

7.2 Opportunities

8 Competitive Assessment

8.1 Laryngoscopes

8.2 Bronchoscopes

9 Pipeline Assessment

9.1 Overview

9.2 Product Profiles

10 Current and Future Players

10.1 Trends in Corporate Strategy

10.2 Company Profiles

11 Market Outlook

11.1 Japan

11.2 China

12 Appendix

12.1 Bibliography

12.2 Abbreviations

Source: http://www.researchbeam.com/endoscopy-apac-analysis-and-forecasts-market

About Us:

With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Web: http://www.researchbeam.com

Email Us: [email protected]

LinkedIn: http://www.linkedin.com/company/research-beam

Cardiac Markers Tests - Medical Devices Pipeline Assessment, 2015

Cardiac Markers Tests Medical Devices Pipeline Assessment, 2015 provides an overview of Cardiac Markers Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Markers Tests pipeline products.

Enquiry about report: http://www.researchbeam.com/cardiac-markers-tests-medical-devices-pipeline-assessment-2015-market/enquire-about-report

Scope

Extensive coverage of the Cardiac Markers Tests under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Cardiac Markers Tests and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 21

2 Introduction 22

2.1 Cardiac Markers Tests Overview 22

3 Products under Development 23

3.1 Cardiac Markers Tests - Pipeline Products by Stage of Development 23

3.2 Cardiac Markers Tests - Pipeline Products by Segment 24

3.3 Cardiac Markers Tests - Pipeline Products by Territory 25

3.4 Cardiac Markers Tests - Pipeline Products by Regulatory Path 26

3.5 Cardiac Markers Tests - Pipeline Products by Estimated Approval Date 27

3.6 Cardiac Markers Tests - Ongoing Clinical Trials 28

4 Cardiac Markers Tests - Pipeline Products under Development by Companies 29

4.1 Cardiac Markers Tests Companies - Pipeline Products by Stage of Development 29

4.2 Cardiac Markers Tests - Pipeline Products by Stage of Development 35

5 Cardiac Markers Tests Companies and Product Overview 45

5.1 3PrimeDx, Inc. Company Overview 45

5.2 Abbott Diagnostics Company Overview 46

5.3 ACS Biomarker Company Overview 62

5.4 Adaltis S.r.l. Company Overview 63

5.5 AgPlus Diagnostics LTD Company Overview 64

5.6 Alere Inc. Company Overview 65

5.7 Alfa Scientific Designs, Inc. Company Overview 68

5.8 Alfa Wassermann Diagnostic Technologies, LLC Company Overview 69

5.9 Alfa Wassermann, Inc. Company Overview 72

5.10 Amdix B.V. Company Overview 75

6 Cardiac Markers Tests- Recent Developments 357

7 Appendix 415

7.1 Methodology 415

7.2 About GlobalData 417

7.3 Contact Us 418

7.4 Disclaimer 418

Reasons to buy

The report enables you to

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Cardiac Markers Tests under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the products current stage of development, territory and estimated launch date

Source: http://www.researchbeam.com/cardiac-markers-tests-medical-devices-pipeline-assessment-2015-market

About Us:

With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Web: http://www.researchbeam.com

Email Us: [email protected]

LinkedIn: http://www.linkedin.com/company/research-beam

#cardiac markers tests market #cardiac markers tests #global cardiac markers tests market #cardiac markers tests market strategy #cardiac markers tests market application #cardiac markers tests market segmentation #cardiac markers tests market technology #cardiac markers tests market developments #cardiac markers tests market overview #cardiac markers tests market outlook #cardiac markers tests market news #cardiac markers tests market research

Vascular Grafts - Medical Devices Pipeline Assessment, 2015

Vascular Grafts - Medical Devices Pipeline Assessment, 2015 provides an overview of Vascular Grafts currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vascular Grafts pipeline products.

Enquiry about report: http://www.researchbeam.com/vascular-grafts-medical-devices-pipeline-assessment-2015-market/enquire-about-report

Scope

- Extensive coverage of the Vascular Grafts under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 6

2 Introduction 7

2.1 Vascular Grafts Overview 7

3 Products under Development 8

3.1 Vascular Grafts - Pipeline Products by Stage of Development 8

3.2 Vascular Grafts - Pipeline Products by Territory 9

3.3 Vascular Grafts - Pipeline Products by Regulatory Path 10

3.4 Vascular Grafts - Pipeline Products by Estimated Approval Date 11

3.5 Vascular Grafts - Ongoing Clinical Trials 12

4 Vascular Grafts - Pipeline Products under Development by Companies 13

4.1 Vascular Grafts Companies - Pipeline Products by Stage of Development 13

4.2 Vascular Grafts - Pipeline Products by Stage of Development 14

5 Vascular Grafts Companies and Product Overview 15

5.1 3S BioMedical, Inc. Company Overview 15

5.1.1 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15

5.2 Anethon (Inactive) Company Overview 17

5.2.1 Anethon (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 ARISTE Medical Company Overview 18

5.3.1 ARISTE Medical Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 Cardiojustable LLC Company Overview 20

5.4.1 Cardiojustable LLC Pipeline Products & Ongoing Clinical Trials Overview 20

5.5 CryoLife, Inc. Company Overview 21

5.5.1 CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 DSM Biomedical B.V. Company Overview 23

5.6.1 DSM Biomedical B.V. Pipeline Products & Ongoing Clinical Trials Overview 23

5.7 Eqalix, Inc. Company Overview 24

5.7.1 Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24

5.8 FIT Biotech Oy Company Overview 26

5.8.1 FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 26

5.9 Gel-Del Technologies, Inc. Company Overview 28

5.9.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28

5.10 Graftworx, LLC Company Overview 29

5.10.1 Graftworx, LLC Pipeline Products & Ongoing Clinical Trials Overview 29

5.11 Healionics Corporation Company Overview 30

5.11.1 Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview 30

5.12 Innovia LLC Company Overview 31

5.12.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 31

5.13 MultiGene Vascular Systems (MGVS) Ltd. Company Overview 32

5.13.1 MultiGene Vascular Systems (MGVS) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 32

5.14 NuVascular Technologies Inc Company Overview 34

5.14.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 34

5.15 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 35

5.15.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 35

5.16 SurgaColl Technologies Ltd Company Overview 36

5.16.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

5.17 Universidad de Los Andes Company Overview 37

5.17.1 Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview 37

5.18 VesselTek BioMedical LLC Company Overview 38

5.18.1 VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 38

5.19 Xeltis AG Company Overview 41

5.19.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 41

6 Vascular Grafts- Recent Developments 44

7 Appendix 46

7.1 Methodology 46

7.2 About GlobalData 48

7.3 Contact Us 49

7.4 Disclaimer 49

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Vascular Grafts under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the products current stage of development, territory and estimated launch date

Source: http://www.researchbeam.com/vascular-grafts-medical-devices-pipeline-assessment-2015-market

About Us:

With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Web: http://www.researchbeam.com

Email Us: [email protected]

LinkedIn: http://www.linkedin.com/company/research-beam

Gas Turbine Market, Update 2015 - Global Market Size, Equipment Segmentation, Average Pricing and Competitive Landscape Analysis to 2020

Gas Turbine Market, Update 2015 - Global Market Size, Equipment Segmentation, Average Pricing and Competitive Landscape Analysis to 2020â€ is the latest market analysis report, the industry analysis specialists that offer comprehensive information and understanding of the power industry.

Enquiry about report: http://www.researchbeam.com/gas-turbine-update-2015-global-size-equipment-segmentation-average-pricing-and-competitive-landscape-analysis-to-2020-market/enquire-about-report

The report gives detailed information on the current gas turbine market, focusing on key countries, as well as covering the global scenario. The report analyzes the revenues, average price and volume sales of gas turbines by capacity ratings used for power generation in key ten countries in the market. The market shares for the key players in each country have been provided. At global level, the drivers and restraints of the market is also provided. The report is built using data and information sourced from primary and secondary research and in-house analysis by team of industry experts.

Scope

The report analyses global gas turbine market. Its scope includes -

- An in-depth analysis of the gas turbine market in China, US, Saudi Arabia, Turkey, Nigeria, Iran, Mexico, Australia, Brazil and Germany

- Covering average price, volume (in terms of MW) and market size for the period from 2006 to 2020 for gas turbines.

- Market share of players/leading players for gas turbines in 2014.

- It discusses the key drivers and restraints impacting the global gas turbine market.

Table of Contents

1 Table of Contents

1 Table of Contents 4

1.1 List of Tables 8

1.2 List of Figures 11

2 Introduction 14

2.1 Gas Turbines, Overview 14

2.2 GlobalData Report Guidance 16

3 Gas Turbine Market, Global 17

3.1 Gas Turbine Market, Global, Overview 17

3.2 Gas Turbine Market, Global, Drivers, 2015-2020 17

3.2.1 Climate Concerns Promote Gas Power Generation 17

3.2.2 The Commonwealth of Independent States and the Middle East and North Africa Region are Prospective Markets for Gas Turbine Manufacturers 17

3.2.3 Low Construction Costs and Quick Start-Up Times 18

3.3 Gas Turbine Market, Global, Restraints, 2015-2020 18

3.3.1 Gas Prices and Availability Create Uncertainty 18

3.3.2 Macroeconomic and Political Stability 19

3.4 Gas Turbine Market, Global, Revenue and Volume, 2006-2020 20

3.4.1 Gas Turbine Market, Global, Average Price, 2006-2020 24

3.5 Gas Turbine Market, Global, Market Share, 2014 26

4 Gas Turbine Market, Major Countries 27

4.1 Gas Turbine Market, China 27

4.1.1 Gas Turbine Market, China, Overview 27

4.1.2 Gas Turbine Market, China, Drivers 27

4.1.3 Gas Turbine Market, China, Restraints 30

4.1.4 Gas Turbine Market, China, Revenue and Volume, 2006-2020 30

4.1.5 Gas Turbine Market, China, Pricing Analysis 35

4.1.6 Gas Turbine Market, China, Market Share 38

4.1.7 Gas Turbine Market, China, Regulations and Key Initiatives 39

4.2 Gas Turbine Market, US 42

4.2.1 Gas Turbine Market, US, Overview 42

4.2.2 Gas Turbine Market, US, Drivers 42

4.2.3 Gas Turbine Market, US, Restraints 44

4.2.4 Gas Turbine Market, US, Revenue and Annual Capacity Addition, 2006-2020 44

4.2.5 Gas Turbine Market, US, Pricing Analysis 49

4.2.6 Gas Turbine Market, US, Market Share 52

4.2.7 Gas Turbine Market, US, Regulations and Key Initiatives 54

4.3 Gas Turbine Market, Saudi Arabia 55

4.3.1 Gas Turbine Market, Saudi Arabia, Overview 55

4.3.2 Gas Turbine Market, Saudi Arabia, Drivers 56

4.3.3 Gas Turbine Market, Saudi Arabia, Restraints 57

4.3.4 Gas Turbine Market, Saudi Arabia, Revenue and Volume, 2006-2020 58

4.3.5 Gas Turbine Market, Saudi Arabia, Pricing Analysis 63

4.3.6 Gas Turbine Market, Saudi Arabia, Market Share 66

4.3.7 Gas Turbine Market, Saudi Arabia, Regulations and Key Initiatives 67

4.4 Gas Turbine Market, Turkey 68

4.4.1 Gas Turbine Market, Turkey, Overview 68

4.4.2 Gas Turbine Market, Turkey, Drivers 68

4.4.3 Gas Turbine Market, Turkey, Restraints 69

4.4.4 Gas Turbine Market, Turkey, Revenue and Volume, 2006-2020 69

4.4.5 Gas Turbine Market, Turkey, Pricing Analysis 74

4.4.6 Gas Turbine Market, Turkey, Market Share 77

4.4.7 Gas Turbine Market, Turkey, Regulations and Key Initiatives 77

4.5 Gas Turbine Market, Nigeria 80

4.5.1 Gas Turbine Market, Nigeria, Overview 80

4.5.2 Gas Turbine Market, Nigeria, Drivers 80

4.5.3 Gas Turbine Market, Nigeria, Restraints 81

4.5.4 Gas Turbine Market, Nigeria, Revenue and Annual Capacity Addition, 2006-2020 81

4.5.5 Gas Turbine Market, Nigeria, Pricing Analysis 86

4.5.6 Gas Turbine Market, Nigeria, Market Share 89

4.5.7 Gas Turbine Market, Nigeria, Regulations and Key Initiatives 90

4.6 Gas Turbine Market, Iran 92

4.6.1 Gas Turbine Market, Iran, Overview 92

4.6.2 Gas Turbine Market, Iran, Drivers 92

4.6.3 Gas Turbine Market, Iran, Restraints 93

4.6.4 Gas Turbine Market, Iran, Revenue and Volume, 2006-2020 93

4.6.5 Gas Turbine Market, Iran, Pricing Analysis 98

4.6.6 Gas Turbine Market, Iran, Market Share 101

4.6.7 Gas Turbine Market, Iran, Regulations and Key Initiatives 101

4.7 Gas Turbine Market, Mexico 104

4.7.1 Gas Turbine Market, Mexico, Overview 104

4.7.2 Gas Turbine Market, Mexico, Drivers 105

4.7.3 Gas Turbine Market, Mexico, Restraints 106

4.7.4 Gas Turbine Market, Mexico, Revenue and Annual Capacity Addition, 2006-2020 106

4.7.5 Gas Turbine Market, Mexico, Pricing Analysis 111

4.7.6 Gas Turbine Market, Mexico, Market Share 114

4.7.7 Gas Turbine Market, Mexico, Regulations and Key Initiatives 115

4.8 Gas Turbine Market, Australia 119

4.8.1 Gas Turbine Market, Australia, Overview 119

4.8.2 Gas Turbine Market, Australia, Drivers 119

4.8.3 Gas Turbine Market, Australia, Restraints 120

4.8.4 Gas Turbine Market, Australia, Market Revenue, 2006-2020 121

4.8.5 Gas Turbine Market, Australia, Pricing Analysis 126

4.8.6 Gas Turbine Market, Australia, Market Share 129

4.8.7 Gas Turbine Market, Australia, Regulations and Key Initiatives 131

4.9 Gas Turbine Market, Brazil 132

4.9.1 Gas Turbine Market, Brazil, Overview 132

4.9.2 Gas Turbine Market, Brazil, Drivers 132

4.9.3 Gas Turbine Market, Brazil, Restraints 133

4.9.4 Gas Turbine Market, Brazil, Revenue and Annual Capacity Addition, 2006-2020 134

4.9.5 Gas Turbine Market, Brazil, Average Price 139

4.9.6 Gas Turbine Market, Brazil, Market Share 140

4.9.7 Gas Turbine Market, Brazil, Regulations and Key Initiatives 140

4.10 Gas Turbine Market, Germany 142

4.10.1 Gas Turbine Market, Germany, Overview 142

4.10.2 Gas Turbine Market, Germany, Drivers 143

4.10.3 Gas Turbine Market, Germany, Restraints 144

4.10.4 Gas Turbine Market, Germany, Revenue and Annual Capacity Addition, 2006-2020 145

4.10.5 Gas Turbine Market, Germany, Average Price 150

4.10.6 Gas Turbine Market, Germany, Market Share 151

4.10.7 Gas Turbine Market, Germany, Regulations and Key Initiatives 152

5 Appendix 154

5.1 Definitions 154

5.1.1 Power 154

5.1.2 Installed Capacity 154

5.1.3 Electricity Generation 154

5.1.4 Electricity Consumption 154

5.1.5 Thermal Power Plant 154

5.1.6 Hydropower Plant 154

5.1.7 Nuclear Power 154

5.1.8 Renewable Energy Resources 155

5.1.9 Repowering 155

5.2 Abbreviations 156

5.3 Bibliography 158

5.4 Methodology 162

5.4.1 Secondary Research 162

5.4.2 Primary Research 163

5.5 Disclaimer 163

Source: http://www.researchbeam.com/gas-turbine-update-2015-global-size-equipment-segmentation-average-pricing-and-competitive-landscape-analysis-to-2020-market

About Us:

With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Web: http://www.researchbeam.com

Email Us: [email protected]

LinkedIn: http://www.linkedin.com/company/research-beam

#gas turbine market #gas turbine #global gas turbine market #gas turbine market size #gas turbine market share #gas turbine market trends #gas turbine market forecast #gas turbine market futures #gas turbine market opportunities #gas turbine market news

Clostridium difficile Infections (CDI) — Opportunity Analysis and Forecasts to 2024

Clostridium difficile, a Gram-positive, spore-forming, toxin-producing, non-invasive, anaerobic bacterium, is the causative organism of C. difficile infection (CDI), which is commonly associated with colitis, as well as C. difficile-associated diarrhea (CDAD).

Enquiry about report: http://www.researchbeam.com/opportunityanalyzer-clostridium-difficile-infections-cdi-opportunity-analysis-and-forecasts-to-2024-market/enquire-about-report

Summary

CDI onset begins with colonization of the intestinal tract with C. difficile through community-acquired or healthcare-associated means. C. difficile has been identified as a major cause of antibiotic-associated pseudomembranous colitis and diarrhea, with the earliest cases largely attributed to clindamycin. As penicillins and cephalosporins became more widely used throughout the years, their administration also became associated with an increased risk of developing CDAD. Since 2000, CDIs have become more frequent, more severe, more difficult to treat using existing therapies, and more likely to recur than previously described. These realities, along with increasing threat of antibiotic resistance, underscore the importance of developing CDI-specific therapies and bringing them to market.

Scope

- Overview of CDI, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and current treatment options.

- Topline CDI therapeutics and prophylactics market revenue from 2014-2024. Annual cost of therapy (ACOT) and major pipeline product sales in this forecast period are included.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs, opportunities, and R&D strategies for the CDI market.

- Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, synopses of innovative early-stage projects, and detailed analysis of late-stage pipeline products. An interactive clinical and commercial analyzer tool is available.

- Analysis of the current and future market competition in the global CDI market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Table Of Contents

1 Table of Contents 12

2 Introduction 23

3 Disease Overview 26

4 Epidemiology 45

5 Current Treatment Options 83

6 Unmet Needs Assessment and Opportunity Analysis 116

7 Research and Development Strategies 140

8 Pipeline Assessment 160

9 Pipeline Valuation Analysis 235

10 Appendix 261

Reasons to buy

The report will enable you to -

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global CDI therapeutic and prophylactic markets.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the CDI market in the future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Source: http://www.researchbeam.com/opportunityanalyzer-clostridium-difficile-infections-cdi-opportunity-analysis-and-forecasts-to-2024-market

About Us:

With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Web: http://www.researchbeam.com

Email Us: [email protected]

LinkedIn: http://www.linkedin.com/company/research-beam

#clostridium difficile infections #clostridium difficile infections market size #clostridium difficile infections market share #clostridium difficile infections market trends #clostridium difficile infections market forecast #clostridium difficile infections market futures #clostridium difficile infections market opportunities

North and South America Renewable Energy Policy Handbook 2015

Summary

North and South America Renewable Energy Policy Handbook 2015 is the latest policy report, the industry analysis specialists that offer comprehensive information on major policies governing renewable energy market in the region. The report presents an in-depth analysis of the renewable energy policies across the major countries in North and South America namely the US, Canada, Argentina, Brazil and Mexico. It also presents the major renewable policy frameworks in place in some of the major states in the US and Canada. The report provides the current and future renewable energy targets and plans along with the present policy framework, giving a fair idea of overall growth potential of their renewable energy industry. The report also provides major technology specific policies and incentives provided in each of these countries. The report also provides insights to major policy initiatives for the market development of renewable energy sources such as wind, solar, geothermal, biopower and biofuels.

Scope

The report covers policy measures and incentives used by the major countries in North and South America region to promote renewable energy.

The report details promotional measures in different countries both for the overall renewable energy industry and for specific renewable energy technologies namely solar, wind, geothermal, hydro and bioenergy.

The report also highlights the differences and focus of the renewable energy policy frameworks in different countries in North and South America.

The report provides a platform for comparison of various renewable energy policies across countries. Major countries include the US, Canada, Argentina, Brazil and Mexico.

List of Tables

1.1 List of Tables

Table 1: Renewable Energy Market, US, Production Tax Credit ($/kWh), 2014 28

Table 2: Renewable Energy Market, US, Treasury Grant Credit Availability and Eligibility, 2013 30

Table 3: Renewable Energy Market, US, Treasury Grants by Technology, Share of Value, 2009-2014 31

Table 4: Renewable Energy Market, US, Treasury Grants by Technology, Share of Volume, 2009 to July 30, 2013 32

Table 5: Renewable Energy Market, US, Green Power Purchasing Goal (%), 2007-2013 38

Table 6: Solar PV, US, Annual Installed Capacity (GW), 2001-2015 41

Table 7: Wind Power, US, Annual Installed Capacity (GW), 2001-2015 44

Table 8: Small Hydropower, US, Annual Installed Capacity (MW), 2001-2015 46

Table 9: Geothermal Power, US, Annual Installed Capacity (MW), 2001-2013 49

Table 10: Geothermal Power, US, Geothermal Technologies Program Annual Funding ($m), 2006-2014 50

Table 11: Biopower, US, Annual Installed Capacity (MW), 2001-2015 52

Table 12: Biofuels, US, Minimum Share of Renewable Fuel (%), 2014 56

Table 13: Biofuels, US, Required Renewable Transport Fuel Sales (billion gallons), 2008-2022 57

Table 14: Gasoline, US, Volumetric Ethanol Excise Tax Credit ($/gallon), 2007 58

Table 15: Renewable Power, US, Renewable Portfolio Standards, State Targets, 2014 63

Table 16: Renewable Energy Market, Minnesota, Renewable Portfolio Standards for Xcel Energy and Other Utilities (%), 2010-2025 74

Table 17: Renewable Energy Market, Washington, Renewable Energy Standards (%), 2012-2020 onward 81

Table 18: Renewable Energy Market, Washington, Member-Owned Renewable Energy Program Rate ($/kWh), 2010-2015 83

Table 19: Renewable Energy Market, Colorado, Renewable Portfolio Standard (%), 2007-2020 onward 90

Table 20: Renewable Energy Market, Colorado, Capital Cost Threshold Rates, 2014 94

Table 21: Alternative Fuel, Colorado, Excise Taxes ($/gallon), 2014-2019 onward 98

Table 22: Alternative Fuel, Colorado, Excise Taxes ($/gallon), 2014-2021 99

Table 23: Renewable Energy Market, California, Nominal Feed-in Tariffs ($/kWh), 2012-2020 112

Table 24: Renewable Energy Market, California, Procurement Requirement after Third Renewable Mechanism Auction (MW), 2010-2013 113

Table 25: Renewable Energy Market, California, Go Solar Campaign Program Components, 2007-2016 115

Table 26: Renewable Energy Market, California, California Solar Initiative Program Budget ($m), 2007-2016 115

Table 27: Renewable Energy Market, California, California Solar Initiative Rebate Levels by Incentive Step and Rebate Type, 2012 116

Table 28: Renewable Energy Market, California, California Solar Initiative, Details by Incentive Type, 2013 117

Table 29: Renewable Portfolio Standard, Nevada (%), 2005-2025 onward 124

Table 30: Renewable Energy Market, New Jersey, Renewable Portfolio Standards (%), 2004-2028 onward 129

Table 31: Renewable Energy Market, New Jersey, Solar Alternative Compliance Payment ($/MWh), 2008-2028 136

Table 32: Renewable Energy Market, New Jersey, Initial Eight-Year Schedule of Solar Alternative Compliance Payment ($/MWh), 2008-2016 137

Table 33: Renewable Energy Market, Oregon, Renewable Portfolio Standards (%), 2011-2025 149

Table 34: Renewable Energy Market, Oregon, RPS-Eligible Resource Types Based on Facility Operational Date, 1995-2025 150

Table 35: Renewable Energy Market, Oregon, Renewable Energy Tax Credit, 2013 154

Table 36: Renewable Energy Market, Argentina, Renewable Energy in Rural Markets, Total Program Cost ($m), 2005-2012 163

Table 37: Renewable Energy Auctions, Brazil, 2007-2014 174

Table 38: Biodiesel and Mineral Diesel, Brazil, Federal Taxes 184

Table 39: Renewable Energy Market, Mexico, Energy Efficiency Framework, Loans under Green Mortgage Program (MXN), 2013 201

Table 40: Renewable Energy Market, Canada, Provincial Targets and Policies, 2010-2016 206

Table 41: Biorefining Commercialization and Market Development Program and Bioenergy Infrastructure Development Program Grant Recipients, Alberta, 2007-2011 214

Table 42: Renewable Energy Market, Nova Scotia, Community Feed-in Tariffs (CAD/kWh), 2011 224

Table 43: Renewable Energy Market, Ontario, Feed-in Tariff Prices (CAD/kWh), 2014 228

Table 44: Green Energy Act, Ontario, Additional Price Incentives on Feed-in Tariff, 2014 229

Table 45: Abbreviations 243

List of Figures

1.2 List of Figures

Figure 1: Renewable Energy Market, US, Impact Analysis of Various Policies, 1992-2015 22

Figure 2: Renewable Energy Market, US, Policy Impact on Applicable Renewable Energy Sources, 2014 23

Figure 3: Renewable Energy Market, US, Production Tax Credit ($/kWh), 2014 27

Figure 4: Renewable Energy Market, US, Treasury Grants by Technology, Share of Value (%), 2009-2014 31

Figure 5: Renewable Energy Market, US, Treasury Grants by Technology, Volume (%), 2009-2014 32

Figure 6: Solar PV, US, Annual Installed Capacity Addition (GW), 2001-2015 40

Figure 7: Wind Power, US, Annual Installed Capacity (GW), 2001-2015 43

Figure 8: Small Hydropower, US, Annual Installed Capacity Addition (MW), 2001-2015 45

Figure 9: Geothermal Power, US, Annual Installed Capacity Addition (MW), 2001-2013 48

Figure 10: Biopower, US, Annual Installed Capacity Addition (MW), 2001-2015 51

Figure 11: Biofuels, US, Required Renewable Transport Fuel Sales (billion gallons), 2008-2022 56

Figure 12: Renewable Energy Market, Washington, Renewable Energy Standards (%), 2012-2020 onward 81

Figure 13: Renewable Energy Market, Nevada, Renewable Portfolio Standards (%), 2005-2025 onward 124

Figure 14: Renewable Energy Market, Oregon, Renewable Portfolio Standards (%), 2011-2025 148

Figure 15: Renewable Energy Market, Argentina, Impact Analysis of Policies, 2001-2015 162

Figure 16: Renewable Energy Market, Brazil, Impact Analysis of Policies, 2002-2013 171

Figure 17: Renewable Energy Market, Mexico, Policy Impact Analysis, 2002-2013 187

Figure 18: Renewable Energy Market, Canada, Impact Analysis of Various Policies, 2000-2015 204

Figure 19: Renewable Energy Market, Canada, Policy Impact on Applicable Renewable Power Sources, 2015 205

Reasons to buy

Develop business strategies with the help of specific insights about policy decisions being taken on renewable energy by different markets.

Identify opportunities and challenges in exploiting the renewable energy markets.

Compare the level of support provided to different renewable energy technologies in different countries.

Increase future revenue and profitability with the help of insights on the future opportunities and critical success factors in the renewable energy market.

Be ahead of competition by keeping yourself abreast of all the latest policy changes.

Source: http://www.researchbeam.com/north-and-south-america-renewable-energy-policy-handbook-2015-market

About Us:

With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Web: http://www.researchbeam.com

Email Us: [email protected]

LinkedIn: http://www.linkedin.com/company/research-beam

Polyethylene Terephthalate (PET) Industry Outlook in Germany to 2019

Polyethylene Terephthalate (PET) Industry Outlook in Germany to 2019 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants, provides in-depth coverage of Germanys PET industry and presents major market trends. The report covers Germanys PET plants and presents installed capacity information. It also gives historical and forecast market size, demand and production forecasts, end-use demand details, price trends, trade balance data, and company shares of the countrys leading PET producers to provide comprehensive coverage of all parameters of the PET industry.

Enquiry about report: http://www.researchbeam.com/polyethylene-terephthalate-pet-industry-outlook-in-germany-to-2019-size-company-share-price-trends-capacity-forecasts-of-all-active-and-planned-plants-market/enquire-about-report

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Germany Polyethylene Terephthalate (PET) Industry, Supply Scenario, 2005-2019 5

Germany Polyethylene Terephthalate (PET) Industry, Total Plant Capacity, 2005-2019 5

Germany Polyethylene Terephthalate (PET) Industry, Company Share, 2014 9

Germany Polyethylene Terephthalate (PET) Industry, Market Dynamics, 2005-2019 10

Germany Polyethylene Terephthalate (PET) Industry, Market Size, 2005-2019 10

Germany Polyethylene Terephthalate (PET), Demand and Production Outlook, 2005-2019 12

Germany Polyethylene Terephthalate (PET) Industry, Demand by End Use Sector, 2014 14

Germany, Polyethylene Terephthalate (PET) Industry, Price Forecasts, 2005-2019 16

Germany Polyethylene Terephthalate (PET), Trade Balance, 2005-2019 18

Germany Polyethylene Terephthalate (PET) Industry, Imports and Exports, 2005-2019 18

Germany Polyethylene Terephthalate (PET) Industry, Net Exports, 2005-2019 20

Germany Polyethylene Terephthalate (PET) Industry, Imports as Percentage of Demand, 2005-2019 22

Kuwait Petroleum Corporation, Company Snapshot 24

Kuwait Petroleum Corporation, Company Overview 24

Kuwait Petroleum Corporation, Key Information 24

Kuwait Petroleum Corporation, Business Description 24

Business Overview 24

Exploration and Production 25

Refining and Industry 25

Supporting Services 26

Transportation 26

Kuwait Petroleum Corporation, Polyethylene Terephthalate (PET) Market, 2014 27

Kuwait Petroleum Corporation, Polyethylene Terephthalate (PET) Capacity Split, Germany and Rest of the World, 2014 27

Kuwait Petroleum Corporation, Polyethylene Terephthalate (PET) Plant Capacity Share in Germany, 2014 27

Kuwait Petroleum Corporation, Polyethylene Terephthalate (PET) Capacity in Germany, 2005-2019 28

Kuwait Petroleum Corporation, Polyethylene Terephthalate (PET) Plant Details in Germany, 2014 28

SWOT Analysis 29

Overview 29

Kuwait Petroleum Corporation Strengths 29

Kuwait Petroleum Corporation Weakness 30

Kuwait Petroleum Corporation Opportunities 30

Kuwait Petroleum Corporation Threats 31

The Dow Chemical Company, Company Snapshot 33

The Dow Chemical Company, Company Overview 33

The Dow Chemical Company, Key Information 33

The Dow Chemical Company, Business Description 33

Business Overview 33

The Dow Chemical Company, Polyethylene Terephthalate (PET) Market, 2014 35

The Dow Chemical Company, Polyethylene Terephthalate (PET) Capacity Split, Germany and Rest of the World, 2014 35

The Dow Chemical Company, Polyethylene Terephthalate (PET) Plant Capacity Share in Germany, 2014 35

The Dow Chemical Company, Polyethylene Terephthalate (PET) Capacity in Germany, 2005-2019 36

The Dow Chemical Company, Polyethylene Terephthalate (PET) Plant Details in Germany, 2014 36

SWOT Analysis 37

Overview 37

The Dow Chemical Company Strengths 37

The Dow Chemical Company Weaknesses 38

The Dow Chemical Company Opportunities 38

The Dow Chemical Company Threats 39

Appendix 41

Definitions 41

Installed Plant Capacity 41

Abbreviations 41

GlobalDatas Methodology 41

Coverage 41

Secondary Research 41

Primary Research 42

Expert Panel Validation 42

Contact Us 42

Disclaimer 43

Source: http://www.researchbeam.com/polyethylene-terephthalate-pet-industry-outlook-in-germany-to-2019-size-company-share-price-trends-capacity-forecasts-of-all-active-and-planned-plants-market

About Us:

With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Web: http://www.researchbeam.com

Email Us: [email protected]

LinkedIn: http://www.linkedin.com/company/research-beam

Allergic Conjunctivitis - Pipeline Review, H2 2015

Allergic Conjunctivitis Pipeline Review, H2 2015, provides an overview of the Allergic Conjunctivitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Allergic Conjunctivitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Allergic Conjunctivitis and special features on late-stage and discontinued projects.

Enquiry about report: http://www.researchbeam.com/allergic-conjunctivitis-pipeline-review-h2-2015-market/enquire-about-report

Scope

The report provides a snapshot of the global therapeutic landscape of Allergic Conjunctivitis

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved in the therapeutics development for Allergic Conjunctivitis and enlists all their major and minor projects

The report summarizes all the dormant and discontinued pipeline projects

A review of the Allergic Conjunctivitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

A detailed assessment of monotherapy and combination therapy pipeline projects

Coverage of the Allergic Conjunctivitis pipeline on the basis of target, MoA, route of administration and molecule type

Latest news and deals relating related to pipeline products

List of Tables

Number of Products under Development for Allergic Conjunctivitis, H2 2015 8

Number of Products under Development by Companies, H2 2015 9

Comparative Analysis by Late Stage Development, H2 2015 10

Comparative Analysis by Clinical Stage Development, H2 2015 11

Comparative Analysis by Early Stage Development, H2 2015 12

Products under Development by Companies, H2 2015 13

Allergic Conjunctivitis - Pipeline by Accolade Pharma LLC, H2 2015 14

Allergic Conjunctivitis - Pipeline by Akari Therapeutics, Plc, H2 2015 15

Allergic Conjunctivitis - Pipeline by Aldeyra Therapeutics, Inc., H2 2015 16

Allergic Conjunctivitis - Pipeline by Allergan Plc, H2 2015 17

Allergic Conjunctivitis - Pipeline by Eleven Biotherapeutics Inc., H2 2015 18

Allergic Conjunctivitis - Pipeline by Griffin Discoveries BV, H2 2015 19

Allergic Conjunctivitis - Pipeline by NicOx S.A., H2 2015 20

Allergic Conjunctivitis - Pipeline by Ocular Therapeutix, Inc., H2 2015 21

Allergic Conjunctivitis - Pipeline by Ohr Pharmaceutical Inc., H2 2015 22

Allergic Conjunctivitis - Pipeline by Oxagen Limited, H2 2015 23

Allergic Conjunctivitis - Pipeline by Sylentis S.A., H2 2015 24

Allergic Conjunctivitis - Pipeline by Xencor, Inc., H2 2015 25

Assessment by Monotherapy Products, H2 2015 26

Number of Products by Stage and Target, H2 2015 28

Number of Products by Stage and Mechanism of Action, H2 2015 30

Number of Products by Stage and Route of Administration, H2 2015 32

Number of Products by Stage and Molecule Type, H2 2015 34

Allergic Conjunctivitis Therapeutics - Recent Pipeline Updates, H2 2015 53

Allergic Conjunctivitis - Dormant Projects, H2 2015 66

Allergic Conjunctivitis - Discontinued Products, H2 2015 67

List of Figures

Number of Products under Development for Allergic Conjunctivitis, H2 2015 8

Number of Products under Development by Companies, H2 2015 9

Comparative Analysis by Clinical Stage Development, H2 2015 11

Comparative Analysis by Early Stage Products, H2 2015 12

Assessment by Monotherapy Products, H2 2015 26

Number of Products by Top 10 Targets, H2 2015 27

Number of Products by Stage and Top 10 Targets, H2 2015 27

Number of Products by Mechanism of Actions, H2 2015 29

Number of Products by Stage and Mechanism of Actions, H2 2015 29

Number of Products by Routes of Administration, H2 2015 31

Number of Products by Stage and Routes of Administration, H2 2015 31

Number of Products by Molecule Types, H2 2015 33

Number of Products by Stage and Molecule Types, H2 2015 33

Reasons to buy

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop strategic initiatives by understanding the focus areas of leading companies

Identify and understand important and diverse types of therapeutics under development for Allergic Conjunctivitis

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Devise corrective measures for pipeline projects by understanding Allergic Conjunctivitis pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Source: http://www.researchbeam.com/allergic-conjunctivitis-pipeline-review-h2-2015-market

About Us:

With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Web: http://www.researchbeam.com

Email Us: [email protected]

LinkedIn: http://www.linkedin.com/company/research-beam

Constipation - Pipeline Review, H2 2015

Constipation - Pipeline Review, H2 2015, provides an overview of the Constipations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Constipation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Constipation and special features on late-stage and discontinued projects.

Enquiry about report: http://www.researchbeam.com/constipation-pipeline-review-h2-2015-market/enquire-about-report

Scope

- The report provides a snapshot of the global therapeutic landscape of Constipation

- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in the therapeutics development for Constipation and enlists all their major and minor projects

- The report summarizes all the dormant and discontinued pipeline projects

- A review of the Constipation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- A detailed assessment of monotherapy and combination therapy pipeline projects

- Coverage of the Constipation pipeline on the basis of target, MoA, route of administration and molecule type

- Latest news and deals relating related to pipeline products

List of Tables

Number of Products under Development for Constipation, H2 2015 10

Number of Products under Development for Constipation - Comparative Analysis, H2 2015 11

Number of Products under Development by Companies, H2 2015 13

Number of Products under Investigation by Universities/Institutes, H2 2015 14

Comparative Analysis by Late Stage Development, H2 2015 15

Comparative Analysis by Clinical Stage Development, H2 2015 16

Comparative Analysis by Early Stage Development, H2 2015 17

Products under Development by Companies, H2 2015 18

Products under Development by Companies, H2 2015 (Contd..1) 19

Products under Investigation by Universities/Institutes, H2 2015 20

Constipation - Pipeline by AlbireoPharma, H2 2015 21

Constipation - Pipeline by Ardelyx, Inc., H2 2015 22

Constipation - Pipeline by Astellas Pharma Inc., H2 2015 23

Constipation - Pipeline by Braintree Laboratories, Inc., H2 2015 24

Constipation - Pipeline by Daiichi Sankyo Company, Limited, H2 2015 25

Constipation - Pipeline by Dong-A Socio Group, H2 2015 26

Constipation - Pipeline by Ironwood Pharmaceuticals, Inc., H2 2015 27

Constipation - Pipeline by Kissei Pharmaceutical Co., Ltd., H2 2015 28

Constipation - Pipeline by RaQualia Pharma Inc., H2 2015 29

Constipation - Pipeline by Rhythm Pharmaceuticals, H2 2015 30

Constipation - Pipeline by Sanwa Kagaku Kenkyusho Co., Ltd., H2 2015 31

Constipation - Pipeline by Shire Plc, H2 2015 32

Constipation - Pipeline by SK Biopharmaceuticals Co., Ltd., H2 2015 33

Constipation - Pipeline by Sucampo Pharmaceuticals, Inc., H2 2015 34

Constipation - Pipeline by Sumitomo Dainippon Pharma Co., Ltd., H2 2015 35

Constipation - Pipeline by Synergy Pharmaceuticals, Inc., H2 2015 36

Assessment by Monotherapy Products, H2 2015 37

Number of Products by Stage and Target, H2 2015 39

Number of Products by Stage and Mechanism of Action, H2 2015 41

Number of Products by Stage and Route of Administration, H2 2015 43

Number of Products by Stage and Molecule Type, H2 2015 45

Constipation Therapeutics - Recent Pipeline Updates, H2 2015 73

Constipation - Dormant Projects, H2 2015 96

List of Figures

Number of Products under Development for Constipation, H2 2015 10

Number of Products under Development for Constipation - Comparative Analysis, H2 2015 11

Number of Products under Development by Companies, H2 2015 12

Comparative Analysis by Late Stage Development, H2 2015 15

Comparative Analysis by Clinical Stage Development, H2 2015 16

Comparative Analysis by Early Stage Products, H2 2015 17

Assessment by Monotherapy Products, H2 2015 37

Number of Products by Top 10 Targets, H2 2015 38

Number of Products by Stage and Top 10 Targets, H2 2015 38

Number of Products by Top 10 Mechanism of Actions, H2 2015 40

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015 40

Number of Products by Top 10 Routes of Administration, H2 2015 42

Number of Products by Stage and Top 10 Routes of Administration, H2 2015 42

Number of Products by Top 10 Molecule Types, H2 2015 44

Number of Products by Stage and Top 10 Molecule Types, H2 2015 44

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop strategic initiatives by understanding the focus areas of leading companies

- Identify and understand important and diverse types of therapeutics under development for Constipation

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Devise corrective measures for pipeline projects by understanding Constipation pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Source: http://www.researchbeam.com/constipation-pipeline-review-h2-2015-market

About Us:

With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Web: http://www.researchbeam.com

Email Us: [email protected]

LinkedIn: http://www.linkedin.com/company/research-beam

Atrial Fibrillation - Pipeline Review, H2 2015

Atrial FibrillationPipeline Review, H2 2015, provides an overview of the Atrial Fibrillations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Atrial Fibrillation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Atrial Fibrillation and special features on late-stage and discontinued projects.

Enquiry about report: http://www.researchbeam.com/atrial-fibrillation-pipeline-review-h2-2015-market/enquire-about-report

List of Tables

Number of Products under Development for Atrial Fibrillation, H2 2015 10

Number of Products under Development for Atrial Fibrillation - Comparative Analysis, H2 2015 11

Number of Products under Development by Companies, H2 2015 13

Number of Products under Investigation by Universities/Institutes, H2 2015 14

Comparative Analysis by Late Stage Development, H2 2015 15

Comparative Analysis by Clinical Stage Development, H2 2015 16

Comparative Analysis by Early Stage Development, H2 2015 17

Products under Development by Companies, H2 2015 18

Products under Development by Companies, H2 2015 (Contd..1) 19

Products under Investigation by Universities/Institutes, H2 2015 20

Atrial Fibrillation - Pipeline by ARCA biopharma, Inc., H2 2015 21

Atrial Fibrillation - Pipeline by Armetheon, Inc., H2 2015 22

Atrial Fibrillation - Pipeline by AstraZeneca Plc, H2 2015 23

Atrial Fibrillation - Pipeline by Bristol-Myers Squibb Company, H2 2015 24

Atrial Fibrillation - Pipeline by Cardiome Pharma Corp., H2 2015 25

Atrial Fibrillation - Pipeline by Daiichi Sankyo Company, Limited, H2 2015 26

Atrial Fibrillation - Pipeline by Gilead Sciences, Inc., H2 2015 27

Atrial Fibrillation - Pipeline by Isis Pharmaceuticals, Inc., H2 2015 28

Atrial Fibrillation - Pipeline by Laboratoires Pierre Fabre SA, H2 2015 29

Atrial Fibrillation - Pipeline by Nissan Chemical Industries, Ltd., H2 2015 30

Atrial Fibrillation - Pipeline by Nyken BV, H2 2015 31

Atrial Fibrillation - Pipeline by Otsuka Holdings Co., Ltd., H2 2015 32

Atrial Fibrillation - Pipeline by Xention Limited, H2 2015 33

Assessment by Monotherapy Products, H2 2015 34

Number of Products by Stage and Target, H2 2015 36

Number of Products by Stage and Mechanism of Action, H2 2015 38

Number of Products by Stage and Route of Administration, H2 2015 40

Number of Products by Stage and Molecule Type, H2 2015 42

Atrial Fibrillation Therapeutics - Recent Pipeline Updates, H2 2015 74

Atrial Fibrillation - Dormant Projects, H2 2015 88

Atrial Fibrillation - Dormant Projects (Contd..1), H2 2015 89

Atrial Fibrillation - Dormant Projects (Contd..2), H2 2015 90

Atrial Fibrillation - Dormant Projects (Contd..3), H2 2015 91

Atrial Fibrillation - Discontinued Products, H2 2015 92

Atrial Fibrillation - Discontinued Products (Contd..1), H2 2015 93

List of Figures

Number of Products under Development for Atrial Fibrillation, H2 2015 10

Number of Products under Development for Atrial Fibrillation - Comparative Analysis, H2 2015 11

Number of Products under Development by Companies, H2 2015 12

Comparative Analysis by Late Stage Development, H2 2015 15

Comparative Analysis by Clinical Stage Development, H2 2015 16

Comparative Analysis by Early Stage Products, H2 2015 17

Assessment by Monotherapy Products, H2 2015 34

Number of Products by Top 10 Targets, H2 2015 35

Number of Products by Stage and Top 10 Targets, H2 2015 35

Number of Products by Top 10 Mechanism of Actions, H2 2015 37

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015 37

Number of Products by Top 10 Routes of Administration, H2 2015 39

Number of Products by Stage and Top 10 Routes of Administration, H2 2015 39

Number of Products by Top 10 Molecule Types, H2 2015 41

Number of Products by Stage and Top 10 Molecule Types, H2 2015 41

Source: http://www.researchbeam.com/atrial-fibrillation-pipeline-review-h2-2015-market

About Us:

With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Web: http://www.researchbeam.com

Email Us: [email protected]

LinkedIn: http://www.linkedin.com/company/research-beam

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H2, 2015

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney Disease (Chronic Renal Failure).

Enquiry about report: http://www.researchbeam.com/chronic-kidney-disease-chronic-renal-failure-global-clinical-trials-review-h2-2015-market/enquire-about-report

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials 15

Clinical Trials by Phase in G7 Countries 17

Clinical Trials in G7 Countries by Trial Status 18

Clinical Trials by E7 Countries: Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials 19

Clinical Trials by Phase in E7 Countries 21

Clinical Trials in E7 Countries by Trial Status 22

Clinical Trials by Phase 23

In Progress Trials by Phase 24

Clinical Trials by Trial Status 25

Clinical Trials by End Point Status 26

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials 31

Prominent Drugs 33

Latest Clinical Trials News on Chronic Kidney Disease (Chronic Renal Failure) 34

Oct 06, 2015: Akebia Reaches Agreement with FDA and EMA on Vadadustat Global Phase 3 Program 34

Oct 05, 2015: Results from Mercks Phase 3 Study of Investigational Chronic Hepatitis C Therapy Elbasvir/Grazoprevir in Patients with Advanced Chronic Kidney Disease Published in The Lancet 34

Oct 05, 2015: Atara Bios Collaborating Investigators to Present Data at the American Society of Nephrology Kidney Week 2015 35

Sep 08, 2015: Akebia Announces Positive Top-Line Results from its Phase 2 Study of Vadadustat in Dialysis Patients with Anemia Related to Chronic Kidney Disease 35

Aug 04, 2015: International Clinical Steering Committee Announced for Resverlogixs Phase 3 BETonMACE Clinical Trial with RVX-208 "apabetalone" 36

Clinical Trial Profile Snapshots 38

Appendix 1020

Abbreviations 1020

Definitions 1020

Research Methodology 1021

Secondary Research 1021

About GlobalData 1022

Contact Us 1022

Disclaimer 1022

Source 1023

List of Tables

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Region, 2015* 6

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 16

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18

Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 20

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 21

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 22

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Phase, 2015* 23

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 24

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 25

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 26

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

Source: http://www.researchbeam.com/chronic-kidney-disease-chronic-renal-failure-global-clinical-trials-review-h2-2015-market

About Us:

With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Web: http://www.researchbeam.com

Email Us: [email protected]

LinkedIn: http://www.linkedin.com/company/research-beam

#chronic renal failure industry developments #chronic renal failure industry research #chronic renal failure industry overview #chronic renal failure industry news #chronic renal failure industry segmentation #chronic renal failure industry application #chronic renal failure industry strategy #chronic renal failure industry analysis #chronic renal failure industry growth #chronic renal failure industry forecast #chronic renal failure industry trends #chronic renal failure industry share

Renal Failure Global Clinical Trials Review, H2, 2015

Renal Failure Global Clinical Trials Review, H2, 2015 provides an overview of Renal Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7) , phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials) .

Enquiry about report: http://www.researchbeam.com/renal-failure-global-clinical-trials-review-h2-2015-market/enquire-about-report

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7) , Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

List of Tables

Renal Failure Therapeutics, Global, Clinical Trials by Region, 2015* 7

Renal Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Renal Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Renal Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Renal Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Renal Failure Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Renal Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Renal Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Renal Failure to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15

Renal Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Renal Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Renal Failure to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18

Renal Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Renal Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Renal Failure Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Renal Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Renal Failure Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Renal Failure Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Renal Failure Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Renal Failure Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Renal Failure Therapeutics, Global, Terminated Clinical Trials, 2015* 33

Renal Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 46

Renal Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 47

Renal Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 48

Renal Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 49

Renal Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 50

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 51

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 55

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 59

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 63

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 67

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 71

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 74

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 76

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2015* 78

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 80

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Austin Health, 2015* 82

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015* 83

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2015* 85

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 86

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 88

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 89

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 91

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2015* 92

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2015* 93

Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 95

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Source: http://www.researchbeam.com/renal-failure-global-clinical-trials-review-h2-2015-market

About Us:

With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Web: http://www.researchbeam.com

Email Us: [email protected]

LinkedIn: http://www.linkedin.com/company/research-beam

#renal failure market developments #renal failure market overview #renal failure market research #renal failure market news #renal failure market segmentation #renal failure market application #renal failure market strategy #renal failure market analysis #renal failure market growth #renal failure market forecast #renal failure market trends #renal failure market share #renal failure market size #renal failure market #renal failure

Egypt Power Market Outlook to 2025, Update 2015 — Market Trends, Regulations, and Competitive Landscape

This report elaborates Egypts power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2025. Detailed analysis of the Egyptian power markets regulatory structure, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided. The report also gives a snapshot of the power sector in Egypt on broad parameters of macroeconomics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario and future potential. Financial performance of the leading power companies is also analyzed in the report.

Enquiry about report: http://www.researchbeam.com/egypt-power-outlook-to-2025-update-2015-trends-regulations-and-competitive-landscape-market/enquire-about-report

Scope

Snapshot of the countrys power sector across parameters macro economics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario and future potential of the power sector.

Statistics for installed capacity, power generation and consumption from 2000 to 2014, forecast for the next 11 years to 2025.

Break-up by technology, including thermal, hydro, renewable and nuclear

Data on leading current and upcoming projects.

Information on grid interconnectivity, transmission and distribution infrastructure and power exports and imports.

Policy and regulatory framework governing the market.

Detailed analysis of top market participant, including market share analysis and SWOT analysis.

Table of Contents

1 Table of Contents

1 Table of Contents 4

1.1 List of Tables 6

1.2 List of Figures 8

2 Introduction 9

2.1 GlobalData Report Guidance 10

3 Egypt, Power Market, Snapshot 11

3.1 Egypt, Power Market, Macro-economic Factors 11

3.2 Egypt, Power Market, Supply Security 13

3.3 Egypt, Power Market, Opportunities 14

3.4 Egypt, Power Market, Challenges 14

4 Egypt, Power Market, Market Analysis 16

4.1 Egypt, Power Market, Supply Structure 16

4.2 Egypt, Power Market, Key Market Players 17

4.3 Egypt, Power Market, Financial Deals 18

4.3.1 Deal Volume and Value Analysis, 2004-August 2015 18

4.3.2 Deals by Type, 2014 20

4.4 Egypt, Power Market, Demand Structure 20

4.4.1 Electricity Consumption by Sector, 2014 22

5 Egypt, Power Market, Regulatory Scenario 23

5.1 Egypt, Power Market, Key Electricity Policies 23

5.1.1 Electricity Law 23

5.1.2 Power Sector Reforms 23

5.1.3 Build, Own, Operate, and Transfer Scheme 24

5.1.4 Renewable Energy Policies 24

6 Egypt, Power Market, Capacity and Generation Overview 28

6.1 Egypt, Power Market, Cumulative Installed Capacity by Fuel Type, 2014 28

6.2 Egypt, Power Market, Cumulative Installed Capacity and Annual Power Generation, 2000-2025 29

6.2.1 Cumulative Installed Thermal Capacity and Annual Thermal Power Generation, 2000-2025 32

6.2.2 Cumulative Installed Hydropower Capacity and Annual Hydropower Generation, 2000-2025 36

6.2.3 Cumulative Installed Nuclear Capacity and Annual Nuclear Power Generation, 2000-2025 39

6.2.4 Cumulative Installed Other Renewable Capacity and Annual Other Renewable Power Generation, 2000-2025 39

7 Egypt, Power Market, Transmission and Distribution Overview 43

7.1 Egypt, Power Market, Transmission Overview 43

7.2 Egypt, Power Market, Distribution Overview 44

7.3 Egypt, Power Market, Grid Interconnection 46

7.3.1 Electricity Import and Export Trends (2000-2014) 47

7.4 Egypt, Power Market, Electricity Trading 48

8 Egypt, Power Market, Competitive Landscape: Snapshot of Leading Power Generating Companies 49

8.1 Key Company in the Egypt Power Market: Egyptian Electricity Holding Company 49

8.1.1 Company Overview 49

8.1.2 Business Description 49

8.1.3 SWOT Overview 51

9 Appendix 55

9.1 Market Definitions 55

9.1.1 Power 55

9.1.2 Installed Capacity 55

9.1.3 Electricity Generation 55

9.1.4 Electricity Consumption 55

9.1.5 Thermal Power Plant 55

9.1.6 Hydropower Plant 55

9.1.7 Nuclear Power 55

9.1.8 Renewable Energy Resources 56

9.2 Abbreviations 56

9.3 Bibliography 57

9.4 GlobalData™s Methodology 58

9.4.1 Coverage 58

9.4.2 Secondary Research and Analysis 58

9.4.3 Primary Research and Analysis 59

9.5 Disclaimer 60

Reasons to buy

Identify opportunities and plan strategies by having a strong understanding of the investment opportunities in the countrys power sector

Identification of key factors driving investment opportunities in the countrys power sector

Facilitate decision-making based on strong historic and forecast data

Develop strategies based on the latest regulatory events

Position yourself to gain the maximum advantage of the industrys growth potential

Identify key partners and business development avenues

Identify key strengths and weaknesses of important market participants

Respond to your competitors business structure, strategy and prospects

Source: http://www.researchbeam.com/egypt-power-outlook-to-2025-update-2015-trends-regulations-and-competitive-landscape-market

About Us:

With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Web: http://www.researchbeam.com

Email Us: [email protected]

LinkedIn: http://www.linkedin.com/company/research-beam

#egypt power market futures #egypt power market overview #egypt power market news #egypt power market segmentation #egypt power market application #egypt power market strategy #egypt power market analysis #egypt power market growth #egypt power market forecast #egypt power market trends #egypt power market share #egypt power market size #egypt power market #power market

Adrenal Insufficiency Global Clinical Trials Review, H2, 2015

Adrenal Insufficiency Global Clinical Trials Review, H2, 2015" provides an overview of Adrenal Insufficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Adrenal Insufficiency.

Enquiry about report: http://www.researchbeam.com/adrenal-insufficiency-global-clinical-trials-review-h2-2015-market/enquire-about-report

Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Datas proprietary database Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Source: http://www.researchbeam.com/adrenal-insufficiency-global-clinical-trials-review-h2-2015-market

About Us:

With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Web: http://www.researchbeam.com

Email Us: [email protected]

LinkedIn: http://www.linkedin.com/company/research-beam

Trending Blogs

Recently Viewed Blogs

Healthcare and Research